| BSE: 532649 | Sector: Health care |
| NSE: NECLIFE | ISIN Code: INE023H01027 |
| BSE 00:00 | 28 Feb | 11.06 |
-0.62 (-5.31%) |
OPEN
11.44 |
HIGH
11.45 |
LOW
11.05 |
| NSE 00:00 | 28 Feb | 11.05 |
-0.60 (-5.15%) |
OPEN
11.65 |
HIGH
11.90 |
LOW
11.00 |
| OPEN | 11.44 |
| PREVIOUS CLOSE | 11.68 |
| VOLUME | 25910 |
| 52-Week high | 20.85 |
| 52-Week low | 10.90 |
| P/E | 5.95 |
| Mkt Cap.(Rs cr) | 248 |
| Buy Price | 11.05 |
| Buy Qty | 246.00 |
| Sell Price | 11.06 |
| Sell Qty | 33.00 |
Nectar Lifesciences Ltd is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products. The company manufactures Cephalosporin Active pharmaceutical ingredients, finished dosage forms, Phytochemicals, and hard gelatin capsules at their facilities spread across three Indian states of Punjab, Himachal Pradesh and Jammu. They have developed ...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Sanjiv Goyal | ||||||
| Independent Director : | Shamsher Singh Chauhan | ||||||
| Director : | Vivek Sett | ||||||
| Independent Director : | Ajay Swaroop | ||||||
| Director & Chief Executive Off : | Dinesh Dua | ||||||
| Independent Director : | Guljit Sethi | ||||||
| Nominee : | Meena Verma | ||||||
| Addtnl Independent Director : | Rupinder Tewari | ||||||
| AUDITOR : | Ashwani K Gupta & Associates | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Village Saidpura, Tehsil Derabassi S A S Nagar,Mohali,Punjab-140507 | |||||||
| Ph : 91-1762-308000 | |||||||
| WEBSITE : http://www.neclife.com | |||||||
| E-mail : cs@neclife.com | |||||||
